Long term survival of patients with Stage IV gastric carcinoma

Cancer

Volumn 82, Issue 12, 1998, Pages 2307-2311

  Kakeji, Yoshihiro ^a   Maehara, Yoshihiko ^a   Tomoda, Masaaki ^a   Kabashima, Akira ^a   Ohmori, Mariko ^a   Oda, Shinya ^a   Ohno, Shinji ^a   Sugimachi, Keizo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Gastric carcinoma; p53; Prognosis; Proliferative activity; Stage IV

Indexed keywords

PROTEIN P53;

ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; GASTRECTOMY; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; CARCINOMA; FEMALE; GASTRECTOMY; GENE EXPRESSION; GENES, P53; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032525807     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980615)82:12<2307::AID-CNCR2>3.0.CO;2-P     Document Type: Article

References (24)

1. Maehara Y, Okuyama T, Oshiro T, Baba H, Anai H, Akazawa K, et al. Early carcinoma of the stomach. Surg Gynecol Obstet 1993;177:593-7.
2. Maehara Y, Oshiro T, Baba H, Ohno S, Kohnoe S, Sugimachi K. Lymphatic invasion and potential for tumor growth and metastasis in patients with gastric cancer. Surgery 1995;117: 380-5.
3. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. First English edition. Tokyo: Kanehara & Co., Ltd., 1993.
4. Kodera Y, Yamamura Y, Torii A, Uesaka K, Hirai T, Yasui K, et al. Postoperative staging of gastric carcinoma. A comparison between the UICC stage classification and the 12th edition of the Japanese general rules for gastric cancer study. Scand J Gastroenterol 1996;31:476-80.
5. Lane DP. Mutations of the p53 gene and accumulation of the p53 protein: common steps found in the majority of human cancers. In: Foriner JG, Rhoades JE, editors. Accomplishments in cancer research. Philadelphia: J.B. Lippincott, 1990:252-66.
6. Lane DP. p53, guardian of the genome. Nature 1992;358: 15-6.
7. Fonseca L, Yonemura Y, De Aretxabala X, Yamaguchi A, Miwa K, Miyazaki I. p53 detection as a prognostic factor in gastric cancer. Oncology 1994;51:485-90.
8. Dimova RN, Marcov DV, Gajdardjieva KC, Dabeva MD, Hadjiolov AA. Electron microscopic localization of silver staining NOR-proteins in rat liver nucleoli upon D-galactosamine block of transcription. Eur J Cell Biol 1982;28:272-7.
9. Busch H. Nucleolar proteins: purification, isolation, and functional analysis. In: Hnilica LS, editor. Chromosomal nonhistone proteins. Boca Raton, FL: CRC Press, 1984;233-86.
10. Bravo R, Frank R, Blundel PA, Bravo HM. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326:515-7.
11. Jaskulski D, Deriel JK, Mercer WE, Calabretta B, Baserga R. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA/cyclin. Science 1988;240:1544-6.
12. McCormick D, Hall PA. The complexities of proliferating cell nuclear antigen. Histopathology 1992;21:591-4.
13. Kakeji Y, Korenaga D, Tsujitani S, Baba H, Anai H, Maehara Y, et al. Gastric cancer with p53 overexpression has high potential for metastasizing to lymph nodes. Br J Cancer 1993;67:589-93.
14. Ploton D, Bobichon H, Adnet JJ. Ultrastructural localization of NOR in nucleoli of human breast cancer tissues using a one-step AgNOR staining method. Biol Cell 1982;43:229-32.
15. Kakeji Y, Maehara Y, Adachi Y, Baba H, Mori M, Furusawa M, et al. Proliferative activity as a prognostic factor in Borrmann type 4 gastric carcinoma. Br J Cancer 1994;69:749-53.
16. Dixon WJ. BMDP statistical software manual. Berkeley, CA: University of California Press, 1988:133-744.
17. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972;34:187-220.
18. Wanebo HJ, Kennedy BJ, Chmiel J, Steele GJ, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993;218:583-92.
19. Korenaga D, Tsujiitani S, Haraguchi M, Okamura T, Tamada R, Sugimachi K, et al. Long-term survival in Japanese patients with far advanced carcinoma of the stomach. World J Surg 1988;12:236-40.
20. Yonemura Y, Miyazaki I. Treatment of advanced gastric cancers with liver metastasis [in Japanese]. Dig Surg 1986;9: 1737-47.
21. Kaibara N, Maeta M, Koga S. Treatment of gastric cancer with disseminating peritoneal metastasis [in Japanese]. Dig Surg 1986;9:1749-54.
22. Maehara Y, Sugimachi K, Ogawa M, Kakegawa T, Shimazu H, Tomita M. Influence of preoperative performance status on survival time of patients with advanced gastric cancer following noncurative resection. Anticancer Res 1993;13: 201-4.
23. Muller W, Borchard F. Prognostic influence of p53 expression in gastric cancer. J Pathol 1996;178:255-8.
24. Yamaguchi A, Nakagawara G, Kurosaka Y, Nishimura G, Yonemura Y, Miyazaki I. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance. Br J Cancer 1993;68:399-402.